Experiences of the Patients with Behcet’s Syndrom from Adherence to Treatment: A Qualitative Content Analysis

Document Type : Original Article


1 Student Research Committee, Department of Nursing, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran;

2 Community Based Psychiatric Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;

3 Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;

4 Department of Administration and Educational Planning, School of Education Sciences and Psychology, Shiraz University, Shiraz, Iran;

5 Department of Nursing, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran


Background: Adherence to treatment plays an important role in the effectiveness of treatment in patients with Behcet’s Syndrome (BS). An in-depth understanding of the experiences of patients with BS will help to improve the patients’ management. The present qualitative study aimed to explore the experiences of patients with BS from adherence to treatment.
Methods: This qualitative study was conducted during February-September 2019 at Shahid Motahari Behcet’s Clinic in Shiraz, Iran. Data were collected through eight unstructured observations and 22 individual in-depth semi-structured interviews with 20 participants (15 patients with BS, three family members, and two rheumatologists). Data analysis was performed simultaneously with data collection, using the conventional content analysis as proposed by Graneheim and Lundman. Data were managed using MAXQDA 10 software.
Results: Data analysis resulted in 21 sub-categories, seven categories, and three themes. The themes included barriers to treatment adherence (inability to cope with treatment and challenges in access to health care), facilitators of treatment adherence (incentives, receiving support, and striving to adapt to illness), and missing aspects of the treatment program (inadequate patient education and the neglect of lifestyle modification).
Conclusion: The barriers to and facilitators of treatment adherence as well as the missing aspects of the treatment program of patients with BS were identified. Adherence to treatment is not only determined by the patients, but also affected by the support system and relies upon the existing context and the nature of the treatment plan. These parameters should be considered during patient management to effectively promote treatment adherence.


  1. Esatoglu SN, Kutlubay Z, Ucar D, et al. Behcet’s syndrome: providing integrated care. Journal of Multidisciplinary Healthcare. 2017;10:309-19.
  2. Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet’s disease in Iran: Analysis of 7641 cases. Modern Rheumatology. 2019;29:1023-30.
  3. Scherrer MAR, Rocha VB, Garcia LC. Behçet’s disease: review with emphasis on dermatological aspects. Anais Brasileiros de Dermatologia. 2017;92:452-64.
  4. Leccese P, Alpsoy E. Behçet’s Disease: An Overview of Etiopathogenesis. Frontiers Immunology. 2019;10:1067.
  5. Cinar FI, Cinar M, Yilmaz S, et al. Cross-Cultural Adaptation, Reliability, and Validity of the Turkish Version of the Compliance Questionnaire on Rheumatology in Patients With Behcet’s Disease. Journal of Transcultural Nursing. 2016;27:480-6.
  6. Khabbazi A, Karkon Shayan F, Ghojazadeh M, et al. Adherence to treatment in patients with Behcet’s disease. International Journal of Rheumatic Diseases. 2018;21:2158-66.
  7. van den Bemt BJ, den Broeder AA, van den Hoogen FH, et al. Making the rheumatologist aware of patients’ non-adherence does not improve medication adherence in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2011;40:192-6.
  8. Albuquerque C, Correia C, Ferreira M. Adherence to the Therapeutic Regime in Person with Type 2 Diabetes. Procedia-Social and Behavioral Sciences. 2015;171:350-8.
  9. Hugtenburg JG, Timmers L, Elders PJ, et al. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Preference and Adherence. 2013;7:675-82.

10. Najimi A, Mostafavi F, Sharifirad G, Golshiri P. Barriers to medication adherence in patients with hypertension: A qualitative study. Journal of Education and Health Promotion. 2018;7:24.

11. Zhang L, Tian Y, Ye JF, et al. Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet’s disease in the Shanghai Adamantiades-Behçet’s disease database: a prospective cohort study. Orphanet Journal of Rare Diseases. 2019;14:274.

12. Tai V, Lindsay K, Sims JL, McQueen FM. Qualitative study: the experience and impact of living with Behcet’s syndrome. The New Zealand Medical Journal. 2017;130:27-36.

13. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Education Today. 2004;24:105-12.

14. Lincoln YS, Lynham SA, Guba EG. Paradigmatic Controversies, Contradictions, and Emerging Confluences, Revisited. In: Denzin NK, Lincoln YS, eds. The Sage handbook of qualitative research. 4th ed. US: Sage Publications; 2011.

15. Fort MP, Alvarado-Molina N, Pena L, et al. Barriers and facilitating factors for disease self-management: a qualitative analysis of perceptions of patients receiving care for type 2 diabetes and/or hypertension in San Jose, Costa Rica and Tuxtla Gutierrez, Mexico. BMC Family Practice. 2013;14:131.

16. Kvarnstrom K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. BMJ Open. 2018;8:e015332.

17. Gagani A, Gemao J, Relojo D, Pilao SJ. The dilemma of denial: acceptance and individual coping among patients with chronic kidney diseases. Journal of Educational Science & Psychology. 2016;6:45-52.

18. Jaam M, Mohamed Ibrahim MI, Kheir N, et al. Assessing prevalence of and barriers to medication adherence in patients with uncontrolled diabetes attending primary healthcare clinics in Qatar. Primary Care Diabetes. 2018;12:116-25.

19. Raghunath S, Hijjawi R, Hoon E, et al. Qualitative assessment of medication adherence in patients with rheumatic diseases on biologic therapy. Clinical Rheumatology. 2019;38:2699-707.

20. Dehvan F, Baghi V, Lotfi A, Ghanei Gheshlagh R. Medication adherence inhibitors and facilitators in type 2 diabetic patients: An integrative review. Scientific Journal of Nursing Midwifery and Paramedical Faculty. 2017;3:1-17. [In Persian]

21. Heidari P, Cross W, Weller C, et al. Rheumatologists’ insight into medication adherence in patients with rheumatoid arthritis: A qualitative study. International Journal of Rheumatic Diseases. 2019;22:1695-705.

22. Rezaei M, Valiee S, Tahan M, et al. Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes, Metabolic Syndrome and Obesity. 2019;12:589-99.

23. Dehdari L, Dehdari T. The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes. Archives of Public Health. 2019;77:21.

24. Emami Zeydi A, Karimi Moonaghi H, Heydari A. Exploring Iranian β-Thalassemia major patients’ perception of barriers and facilitators of adherence to treatment: A qualitative study. Electronic Physician. 2017;9:6102-10.

25. Koh JJK, Cheng RX, Yap Y, et al. Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study. Patient Preference and Adherence. 2018;12:2481-98.

26. Alipour A, Aliakbari Dehkordi M, Amini F, Hashemi Jashni A. Relationship between perceived social support and adherence of treatment in Diabetes mellitus type 2: mediating role of resillency and hope. Journal of Research in Psychological Health. 2016;10:53-67. [In Persian]

27. Brandstetter S, Hertig S, Loss J, et al. ‘The lesser of two evils...’ - views of persons with rheumatoid arthritis on medication adherence: a qualitative study. Psychology & Health. 2016;31:675-92.

28. Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of qualitative research on the contributory factors leading to medicine-related problems from the perspectives of adult patients with cardiovascular diseases and diabetes mellitus. BMJ Open. 2014;4:e005992.

29. Vahedparast H, Mohammadi E, Ahmadi F. The Challenge of Adherence From Treatment-Care Regimens Among Patients With Chronic Diseases: A Qualitative Study. Iranian South Medical Journal. 2017;19:989-1004. [In Persian]

30. Ashoorkhani M, Majdzadeh R, Gholami J, et al. Understanding Non-Adherence to Treatment in Hypertension: A Qualitative Study. International Journal of Community Based Nursing and Midwifery. 2018;6:314-23.

31. Jadid Milani M, Ashk Torab T, Abed Saiedi J, Alavi Majd H. The Effect of Peer Support Groups on Promotion of Physical Health Status of Patients Suffering from Multiple Sclerosis. Journal of Research Development in Nursing and Midwifery. 2013;9:1-10. [In Persian].

32. Tehrani AM, Farajzadegan Z, Rajabi FM, Zamani AR. Belonging to a peer support group enhance the quality of life and adherence rate in patients affected by breast cancer: A non-randomized controlled clinical trial. Journal of Research in Medical Sciences. 2011;16:658-65.

33. Baczewska B, Kropornicka B, Sepioło J, et al. Acceptance of illness and satisfaction with life among patients with arterial hypertension. Health Problems in Civilization. 2015;9:31-8.

34. Khademian F, Aslani A, Bastani P. The effects of mobile apps on stress, anxiety, and depression: overview of systematic reviews. International Journal of Technology Assessment in Health Care. 2020;37:e4.

35. Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, et al. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. Journal of Diabetes and Metabolic Disorders. 2013;12:57.

36. Sweileh WM, Zyoud SH, Abu Nab’a RJ, et al. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14:94.

37. Kreyenbuhl J, Leith J, Medoff DR, et al. A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness. Psychiatry Research. 2011;188:109-14.

38. Zareban I, Fallahi A, Nemat-Shahrbabaki B, Pirakalathanan P. Determinants of treatment adherence among women with osteoporosis: A qualitative study in Iran. Health Education and Health Promotion. 2019;7:27-33.

39. Zahmatkeshan N, Rakhshan M, Zarshenas L, et al. The Effect of Applying the Information- Motivation-Behavioral Skills Model on Treatment Adherence in Patients with Cardiovascular Disease: A Quasi-Experimental Study. International Journal of Community Based Nursing & Midwifery. 2021;9:225-37.

40. Khademian Z, Kazemi Ara F, Gholamzadeh S. The Effect of Self Care Education Based on Orem’s Nursing Theory on Quality of Life and Self-Efficacy in Patients with Hypertension: A Quasi-Experimental Study. International Journal of Community Based Nursing and Midwifery. 2020;8:140-9.